Table 2.
Outcome | Event | Person-years | Rate | SHR (95% CI) | p-value |
Admission | |||||
Combined group | |||||
Overall (N = 688) | 646 | 328 | 1969.17 | 1.06 (0.95–1.19) | 0.32 |
HD sessions = 2 (N = 350) | 328 | 209 | 1570.58 | 0.96 (0.84–1.10) | 0.56 |
HD sessions = 3 (N = 28) | 26 | 13 | 2059.98 | 1.11 (0.74–1.66) | 0.61 |
HD sessions = 4 (N = 310) | 292 | 107 | 2739.33 | 1.18 (1.03–1.35) | 0.02 |
Transfer group | 628 | 379 | 1656.15 | Ref. | |
Outcome | Event | Person-years | Rate | HR (95% CI) | p-value |
Mortality | |||||
Combined group | |||||
Overall (N = 688) | 145 | 2413 | 60.09 | 1.02 (0.80–1.30) | 0.88 |
HD sessions = 2 (N = 350) | 79 | 1430 | 55.23 | 1.02 (0.77–1.37) | 0.88 |
HD sessions = 3 (N = 28) | 6 | 116 | 51.66 | 1.31 (0.57–2.99) | 0.52 |
HD sessions = 4 (N = 310) | 60 | 867 | 69.24 | 1.00 (0.73–1.36) | 0.98 |
Transfer group | 155 | 2257 | 68.68 | Ref. |
Rate, per 1000 person-years; SHR subdistribution HR
Adjusted for age, sex, diabetes, chronic heart failure, Charlson comorbidity index, recent peritonitis, and type of vascular access for HD